We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$656M
AUM Growth
+$2.52M
Cap. Flow
-$21.1M
Cap. Flow %
-3.22%
Top 10 Hldgs %
18.98%
Holding
335
New
36
Increased
22
Reduced
128
Closed
29

Sector Composition

Rank Sector Weight
1 Industrials 27.31%
2 Technology 25.7%
3 Healthcare 21.88%
4 Financials 7.67%
5 Communication Services 4.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBNX
26
Beta Bionics
BBNX
$780M
$6.64M 1.01%
217,796
-4,819
-2% -$129K
PRIM icon
27
Primoris Services
PRIM
$4.39B
$6.33M 0.96%
50,981
-4,142
-8% -$541K
EVER icon
28
EverQuote
EVER
$867M
$6.25M 0.95%
231,424
-4,358
-2% -$106K
WMS icon
29
Advanced Drainage Systems
WMS
$10.6B
$6.2M 0.95%
42,835
-63
-0.1% -$9.12K
AMSC icon
30
American Superconductor
AMSC
$1.56B
$6.19M 0.94%
215,154
-30,427
-12% -$1.32M
TVTX icon
31
Travere Therapeutics
TVTX
$5.86B
$6.06M 0.92%
158,709
-3,279
-2% -$107K
UVE icon
32
Universal Insurance Holdings
UVE
$1.18B
$6M 0.91%
177,374
-3,870
-2% -$123K
AMBA icon
33
Ambarella
AMBA
$3.66B
$5.94M 0.91%
83,843
-1,509
-2% -$122K
BWAY
34
Brainsway
BWAY
$666M
$5.79M 0.88%
608,360
-13,008
-2% -$107K
XERS icon
35
Xeris Biopharma Holdings
XERS
$1.55B
$5.77M 0.88%
734,532
-15,502
-2% -$122K
GEV icon
36
GE Vernova
GEV
$277B
$5.62M 0.86%
8,603
-880
-9% -$536K
CRM icon
37
Salesforce
CRM
$158B
$5.05M 0.77%
19,080
-342
-2% -$85K
PATK icon
38
Patrick Industries
PATK
$2.79B
$4.98M 0.76%
45,941
-933
-2% -$97.9K
LYTS icon
39
LSI Industries
LYTS
$890M
$4.93M 0.75%
269,248
-5,899
-2% -$120K
FEIM icon
40
Frequency Electronics
FEIM
$858M
$4.92M 0.75%
91,380
-2,030
-2% -$74.7K
PEGA icon
41
Pegasystems
PEGA
$5.15B
$4.74M 0.72%
79,424
-1,236
-2% -$72.4K
CXDO icon
42
Crexendo
CXDO
$215M
$4.72M 0.72%
729,877
-15,627
-2% -$102K
BWXT icon
43
BWX Technologies
BWXT
$15.8B
$4.71M 0.72%
27,247
-435
-2% -$81.6K
OCUL icon
44
Ocular Therapeutix
OCUL
$2.25B
$4.68M 0.71%
385,825
-8,251
-2% -$100K
ANGO icon
45
AngioDynamics
ANGO
$651M
$4.63M 0.71%
360,544
+33,148
+10% +$409K
MAMA icon
46
Mama's Creations
MAMA
$826M
$4.53M 0.69%
335,624
-6,240
-2% -$71.7K
GWRE icon
47
Guidewire Software
GWRE
$14.4B
$4.53M 0.69%
22,514
-387
-2% -$85.6K
GMED icon
48
Globus Medical
GMED
$11.5B
$4.49M 0.68%
51,409
-1,215
-2% -$92.2K
ORN icon
49
Orion Group Holdings
ORN
$402M
$4.47M 0.68%
449,761
+139,109
+45% +$1.35M
WGO icon
50
Winnebago Industries
WGO
$915M
$4.44M 0.68%
+109,490
New +$3.99M

Similar funds

Essex Investment Management's Q4 2025 Portfolio in Review

As of Q4 2025, Essex Investment Management held 335 positions worth $656M, up 0.39% from $653M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Essex Investment Management withdrew a net $21.1M in Q4 2025, closing 29 positions and reducing 128 holdings. Its most notable exit was ClearPoint Neuro, an estimated $5.07M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, down from 32% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Essex Investment Management opened a new position in Exzeo Group worth $7.06M.

  • Essex Investment Management's largest Q4 2025 buy was Exzeo Group: 291,076 shares worth $7.06M.
  • Essex Investment Management added most to Workiva in Q4 2025, an estimated $3.43M increase.
  • Essex Investment Management's biggest Q4 2025 reduction was Insmed, cutting an estimated $4.5M.
  • Essex Investment Management fully exited ClearPoint Neuro in Q4 2025, selling an estimated $5.07M.
  • Essex Investment Management's ten largest holdings make up 19% of its $656M portfolio in Q4 2025.
  • Essex Investment Management opened 36 new positions and closed 29 in Q4 2025.
  • Essex Investment Management's portfolio value rose 0.39% quarter-over-quarter to $656M.

Based on Essex Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.